Skip to main content
Log in

Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Various inflammation-based prognostic scores have been associated with poor survival in patients with hepatocellular carcinoma (HCC).

Methods

Data were collected retrospectively from 674 HCC patients who underwent curative resection. The correlation between INS (inflammation–nutrition score), BCLC (Barcelona Clinic Liver Cancer) stage and inflammatory indices and overall survival (OS) and disease free survival (DFS) was examined.

Results

An elevated INS was associated with both tumor and host clinical characteristics. The combination of INS and BCLC stage stratifies OS and DFS from 80% and 65% (INS = 0, stage A) to 0% (INS = 2, stage C). Univariate and multivariate analyses revealed that the INS was an independent predictor for OS and DFS, and was superior to inflammation-based scores. In addition, INS was demonstrated to be a prognostic factor for patients with early stage and had a higher AUC value in comparison with inflammation scores.

Conclusion

This study demonstrates that the INS is an independent marker of poor prognosis in patients with resectable HCC, especially for those with early stage, and it provides complimentary prognostic information to BCLC stage, and may aid in treatment strategy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Lindsey A, Torre M, Freddie Bray P et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108

    Article  Google Scholar 

  2. Chen W, Zheng R, Baade PD et al (2016) Cancer statistics in China, 2015. CA Cancer J Clin 2(66):115–132

    Article  Google Scholar 

  3. Ng KK, Lo CM, Liu CL et al (2008) Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant. Arch Surg 143(1):68–74

    Article  PubMed  Google Scholar 

  4. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  5. McAllister SS, Weinberg RA (2014) The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol 16(8):717–727

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Proctor MJ, Morrison DS, Talwar D et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47(17):2633–2641

    Article  PubMed  Google Scholar 

  7. Shrotriya S, Walsh D, Bennani-Baiti N et al (2015) C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review. PLoS One 10(12):e0143080

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Templeton AJ, McNamara MG, Šeruga B et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):dju124

    Article  CAS  PubMed  Google Scholar 

  9. Pang Q, Zhang JY, Xu XS et al (2015) Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J Gastroenterol 21(18):5607–5621

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chan AW, Chan SL, Wong GL et al (2015) Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection. Ann Surg Oncol 22(13):4138–4148

    Article  PubMed  Google Scholar 

  11. Lai Q, Castro Santa E, Rico Juri JM et al (2014) Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer. Transpl Int 27(1):32–41

    Article  CAS  PubMed  Google Scholar 

  12. Yamamura K, Sugimoto H, Kanda M et al (2014) Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepato Biliary Pancreat Sci 21(9):682–688

    Article  Google Scholar 

  13. Proctor MJ, Morrison DS, Talwar D et al (2011) An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 104(4):726–734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kinoshita A, Onoda H, Imai N et al (2013) The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC Cancer 13:52

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pinato DJ, Stebbing J, Ishizuka M et al (2012) A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). J Hepatol 57(5):1013–1020

    Article  PubMed  Google Scholar 

  16. Nakamura M, Iwahashi M, Nakamori M et al (2014) New prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today 44(5):875–883

    Article  CAS  PubMed  Google Scholar 

  17. Arigami T, Okumura H, Matsumoto M et al (2015) Analysis of the fibrinogen and neutrophil-lymphocyte ratio in esophageal squamous cell carcinoma: a promising blood marker of tumor progression and prognosis. Medicine (Baltim) 94(42):e1702

    Article  CAS  Google Scholar 

  18. Hirashima K, Watanabe M, Shigaki H et al (2014) Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol 49(6):1040–1046

    Article  PubMed  Google Scholar 

  19. Kawashima M, Murakawa T, Shinozaki T et al (2015) Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery. Interact Cardiovasc Thorac Surg 21(5):637–643

    Article  PubMed  Google Scholar 

  20. Takeno S, Hashimoto T, Shibata R et al (2014) The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Oncology 87(4):205–214

    Article  PubMed  Google Scholar 

  21. Ishizuka M, Kubota K, Kita J et al (2011) Usefulness of a modified inflammation-based prognostic system for predicting postoperative mortality of patients undergoing surgery for primary hepatocellular carcinoma. J Surg Oncol 103(8):801–806

    Article  PubMed  Google Scholar 

  22. Van Dijk M, Pot GK (2016) The effects of nutritional interventions on recurrence in survivors of colorectal adenomas and cancer: a systematic review of randomised controlled trials. Eur J Clin Nutr 70(5):566–573

    Article  CAS  PubMed  Google Scholar 

  23. Pergialiotis V, Doumouchtsis SK, Perrea D et al (2016) The impact of underweight status on the prognosis of ovarian cancer patients: a meta-analysis. Nutr Cancer 68(6):918–925

    Article  PubMed  Google Scholar 

  24. Mantzorou M, Koutelidakis A, Theocharis S et al (2017) Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer 69(8):1151–1176

    Article  PubMed  Google Scholar 

  25. Davis CJ, Sowa D, Keim KS et al (2012) The use of prealbumin and C-reactive protein for monitoring nutrition support in adult patients receiving enteral nutrition in an urban medical center. J Parenter Enter Nutr 36(2):197–204

    Article  CAS  Google Scholar 

  26. Lee JL, Oh ES, Lee RW et al (2015) Serum albumin and prealbumin in calorically restricted, nondiseased individuals: a systematic review. Am J Med 128(9):1023.e1–1023.e22

    Article  CAS  Google Scholar 

  27. Alifano M, Falcoz PE, Seegers V et al (2011) Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer. J Thorac Cardiovasc Surg 142(5):1161–1167

    Article  CAS  PubMed  Google Scholar 

  28. Kawai H, Ota H (2012) Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg 36(12):2853–2857

    Article  PubMed  Google Scholar 

  29. Zhang L, Su Y, Chen Z et al (2017) The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction. Medicine (Baltim) 96(30):e7647

    Article  Google Scholar 

  30. Han WX, Chen ZM, Wei ZJ et al (2016) Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction. World J Surg Oncol 14(1):279

    Article  PubMed  PubMed Central  Google Scholar 

  31. Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252–7259

    Article  CAS  PubMed  Google Scholar 

  32. Sun HC, Zhang W, Qin LX et al (2007) Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma. J Hepatol 47(5):684–690

    Article  CAS  PubMed  Google Scholar 

  33. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674

    Article  CAS  PubMed  Google Scholar 

  34. Kinoshita A, Onoda H, Imai N et al (2015) C-reactive protein as a prognostic marker in patients with hepatocellular carcinoma. Hepatogastroenterology 62(140):966–970

    PubMed  Google Scholar 

  35. Proctor MJ, McMillan DC, Horgan PG et al (2015) Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study. PLoS ONE 10(3):e0116206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Abe T, Tashiro H, Hattori M et al (2016) Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation. Hepatol Res 46(7):622–633

    Article  CAS  PubMed  Google Scholar 

  37. Amri R, Bordeianou LG, Sylla P et al (2014) Obesity, outcomes and quality of care: body mass index increases the risk of wound-related complications in colon cancer surgery. Am J Surg 207(1):17–23

    Article  PubMed  Google Scholar 

  38. Balentine CJ, Wilks J, Robinson C et al (2010) Obesity increases wound complications in rectal cancer surgery. J Surg Res 163(1):35–39

    Article  PubMed  Google Scholar 

  39. Santoso JT, Barton G, Riedley-Malone S et al (2012) Obesity and perioperative outcomes in endometrial cancer surgery. Arch Gynecol Obstet 285(4):1139–1144

    Article  PubMed  Google Scholar 

  40. Tsai S, Choti MA, Assumpcao L et al (2010) Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg 14(7):1143–1150

    Article  PubMed  Google Scholar 

  41. Bhayani NH, Hyder O, Frederick W et al (2012) Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery 152(2):218–226

    Article  PubMed  Google Scholar 

  42. Suh B, Park S, Shin DW et al (2014) Low albumin-to-globulin ratio associated with cancer incidence and mortality in generally healthy adults. Ann Oncol 25(11):2260–2266

    Article  CAS  PubMed  Google Scholar 

  43. Alifano M, Mansuet-Lupo A, Lococo F et al (2014) Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer. PLoS One 9(9):e106914

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Yang XR, Xu Y, Yu B et al (2010) High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59(7):953–962

    Article  CAS  PubMed  Google Scholar 

  45. Fan ST, Mau Lo C, Poon RT et al (2011) Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 253(4):745–758

    Article  PubMed  Google Scholar 

  46. Poon RT, Fan ST, Lo CM et al (2000) Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 18(5):1094–1101

    Article  CAS  PubMed  Google Scholar 

  47. Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East–West study group. Ann Surg 257(5):929–937

    Article  PubMed  Google Scholar 

  48. EASL-EORTC Clinical Practice Guidelines (2012) Management of hepatocellular carcinoma. J Hepatol 56(4):908–943

    Article  Google Scholar 

  49. Guthrie GJ, Roxburgh CS, Farhan-Alanie OM et al (2013) Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer 109(1):24–28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Okuno M, Ebata T, Yokoyama Y et al (2016) Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma. J Gastroenterol 51(2):153–161

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was in part supported by National Key Sci-Tech Special Project of China (Grant 2012ZX10002010-001/002), the National Natural Science Foundation of China (Grant 81302102), and the Basic Research Programs of Science and Technology Commission Foundation of Shanghai (Grants 13JC1401800, XBR2013074, and 13CG04).

Author information

Authors and Affiliations

Authors

Contributions

Conception/Design: X-CN, JX, and S-JQ. Provision of study material or patients: YY, Y-PF, and X-CN. Collection and/or assembly of data: Y-PF, J-LH, and X-YC. Data analysis and interpretation: GL, J-LH, WG, Y-PF, X-CN, and S-JQ. Manuscript writing: X-CN, JX, and S-JQ. Final approval of manuscript: X-CN and S-JQ.

Corresponding author

Correspondence to Shuang-Jian Qiu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Ethics Committee of Zhongshan Hospital.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ni, XC., Xu, J., Yi, Y. et al. Inflammation–nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma. Int J Clin Oncol 24, 825–835 (2019). https://doi.org/10.1007/s10147-019-01402-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-019-01402-4

Keywords

Navigation